Weibing Yang

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Apr 19, 2023
Targeting CXCL9/10/11-CXCR3 axis: an important component of tumor-promoting and antitumor immunity.

Minjie Pan, Xiaoshan Wei, Xuan Xiang

|Apr 12, 2023
Lutein inhibits tumor progression through the ATR/Chk1/p53 signaling pathway in non-small cell lung cancer.

Si-Yu Zhang, You-Yi Lu, Xin-Liang He

Pageof 1

Frequent Collaborators